Ceftizoxime
Ceftizoxime is a third-generation cephalosporin available for parenteral administration. Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
Clinical data | |
---|---|
Trade names | Cefizox |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a684043 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.210.846 |
Chemical and physical data | |
Formula | C13H13N5O5S2 |
Molar mass | 383.40 g·mol−1 |
Synthesis
Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.
gollark: Basically, spaghetti code is where the whole thing is a horrible tangled mess, yes.
gollark: My theory is that DC is based on spaghetti code so TJ09 can't change stuff without working for ages.
gollark: I just... Why?
gollark: (Pagination + quick rule summary + indicator if person you're trading with is egglocked + few other small things probably)
gollark: God-Emperor TJ09 could fix the whole thing in a few hours, but nooo...
References
- T. Takaya et al., DE 2810922; eidem, U.S. Patent 4,427,674 (1978, 1984 both to Fujisawa).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.